May 21, 2021 / 02:00PM GMT
Sara Parigian -
Good morning, and thank you for joining us for the Palatin KOL Webinar. (Operator Instructions) As a reminder, this conference is being recorded, and a replay will be made available on the Palatin website following the conclusion of the event.
I would now like to turn the call over to your host, Carl Spana, President and Chief Executive Officer of Palatin. Please go ahead, Carl.
Carl Spana - Palatin Technologies, Inc. - Co-Founder, President, CEO & Director
Thank you, Sara. Steve and I would like to welcome all of the attendees that are listening into the Palatin seminar today on melanocortin agonist for ocular diseases. Today, we have actually a very full agenda for you with a number of very distinguished guest speakers, which we'll introduce in a second. You're going to hear a lot today about the melanocortin system and its role in resolving inflammation and in particular, how we're applying it to development of therapeutics for ocular indications.
Just as a housekeeping point, questions will be at the end after all of the
Palatin Technologies Inc Key Opinion Leader Webinar Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
